Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.330 Biomarker disease CTD_human Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma. 26239085 2015
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.330 Biomarker disease BEFREE Detection of bcl-2/JH rearrangement in follicular and diffuse lymphoma: concordant results of peripheral blood and bone marrow analysis at diagnosis. 8494725 1993
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.330 GeneticVariation disease BEFREE Rearrangements of the bcl-2 gene, associated with the t(14;18)(q32;q21) are present in more than 75% of follicular and 30% of diffuse lymphomas of B-cell origin, suggesting that this translocation plays an important role in B-cell lymphomagenesis. 1632463 1992
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.330 AlteredExpression disease BEFREE However, most follicular and diffuse lymphomas without Bcl-2 rearrangement also displayed intense Bcl-2 staining. 1868240 1991
Entrez Id: 596
Gene Symbol: BCL2
BCL2 		0.330 Biomarker disease CTD_human Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. 3287162 1988
Entrez Id: 604
Gene Symbol: BCL6
BCL6 		0.310 Biomarker disease CTD_human Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. 25543051 2015
Entrez Id: 604
Gene Symbol: BCL6
BCL6 		0.310 GeneticVariation disease BEFREE Although rearrangement of the BCL6 gene is the most frequent genetic change among diffuse lymphomas and some follicular lymphomas this is the first report of a patient with MCL associated with BCL6 rearrangement. 9200999 1997
Entrez Id: 11200
Gene Symbol: CHEK2
CHEK2 		0.300 Biomarker disease CTD_human Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma. 26506619 2015
Entrez Id: 3123
Gene Symbol: HLA-DRB1
HLA-DRB1 		0.300 Biomarker disease CTD_human Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. 22096508 2011
Entrez Id: 875
Gene Symbol: CBS
CBS 		0.300 Biomarker disease CTD_human Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. 17119116 2007
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR 		0.300 Biomarker disease CTD_human Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival. 17488658 2007
Entrez Id: 6470
Gene Symbol: SHMT1
SHMT1 		0.300 Biomarker disease CTD_human Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. 17119116 2007
Entrez Id: 635
Gene Symbol: BHMT
BHMT 		0.300 Biomarker disease CTD_human Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. 17119116 2007
Entrez Id: 2356
Gene Symbol: FPGS
FPGS 		0.300 Biomarker disease CTD_human Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. 17119116 2007
Entrez Id: 7037
Gene Symbol: TFRC
TFRC 		0.300 Biomarker disease CTD_human The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. 16904380 2006
Entrez Id: 7298
Gene Symbol: TYMS
TYMS 		0.300 Biomarker disease CTD_human Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. 16365025 2005
Entrez Id: 1440
Gene Symbol: CSF3
CSF3 		0.300 Therapeutic disease CTD_human High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150. 11911406 2002
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1 		0.300 Biomarker disease CTD_human Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. 11406608 2001
Entrez Id: 2052
Gene Symbol: EPHX1
EPHX1 		0.300 Biomarker disease CTD_human Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. 11406608 2001
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.300 Therapeutic disease CTD_human DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL). 11486401 2001
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.300 Therapeutic disease CTD_human Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study. 11732872 2001
Entrez Id: 3440
Gene Symbol: IFNA2
IFNA2 		0.300 Therapeutic disease CTD_human Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. 7515650 1994
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.300 Therapeutic disease CTD_human Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. 7680712 1993
Entrez Id: 8915
Gene Symbol: BCL10
BCL10 		0.300 Biomarker disease CTD_human
Entrez Id: 5551
Gene Symbol: PRF1
PRF1 		0.300 Biomarker disease CTD_human